Patient Name : Mr.
MRIDUL ROY Collected : 19/Jun/2025 06:46PM
Age/Gender : 59 Y 8 M 12 D /M Received : 20/Jun/2025 12:16PM
UHID/MR No : DLKH.0000004407 Reported : 20/Jun/2025 03:03PM
Visit ID : DLKHOPV6776 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PCC LAKHIMPUR DIBRUGARH
IP/OP NO : Center location : ,North Lakhimpur
DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Interval Method
HBA1C (GLYCATED HEMOGLOBIN) , WHOLE BLOOD EDTA
HBA1C, GLYCATED HEMOGLOBIN 7.7 % HPLC
ESTIMATED AVERAGE GLUCOSE 174 mg/dL Calculated
(eAG)
Comment:
Reference Range as per American Diabetes Association (ADA) 2023 Guidelines:
REFERENCE GROUP HBA1C %
NON DIABETIC <5.7
PREDIABETES 5.7 – 6.4
DIABETES ≥ 6.5
DIABETICS
EXCELLENT CONTROL 6–7
FAIR TO GOOD CONTROL 7–8
UNSATISFACTORY CONTROL 8 – 10
POOR CONTROL >10
Note: Dietary preparation or fasting is not required.
1. HbA1C is recommended by American Diabetes Association for Diagnosing Diabetes and monitoring Glycemic
Control by American Diabetes Association guidelines 2023.
2. Trends in HbA1C values is a better indicator of Glycemic control than a single test.
3. Low HbA1C in Non-Diabetic patients are associated with Anemia (Iron Deficiency/Hemolytic), Liver Disorders, Chronic Kidney Disease. Clinical Correlation is
advised in interpretation of low Values.
4. Falsely low HbA1c (below 4%) may be observed in patients with clinical conditions that shorten erythrocyte life span or decrease mean erythrocyte age. HbA1c may
not accurately reflect glycemic control when clinical conditions that affect erythrocyte survival are present.
5. In cases of Interference of Hemoglobin variants in HbA1C, alternative methods (Fructosamine) estimation is recommended for Glycemic Control
A: HbF >25%
B: Homozygous Hemoglobinopathy.
(Hb Electrophoresis is recommended method for detection of Hemoglobinopathy)
*** End Of Report ***
Page 1 of 1
SIN No:BI26357398
R es u lt R ep o rt
PatientID:
Record Date: 2025-06-20 14:27:08
Barcode: BI26357398
Sam pleNo: 06200010
CALIB : Y = 1.1707X + 0.6364
NAME % TIME AREA
A1A 0.5 0.25 8.36
A1B 0.7 0.33 10.98
F 0.4 0.46 6.71
LA1C+ 2.7 0.55 41.62
SA1C 7.7 0.69 94.31
A0 90.1 1.04 1414.39
TOTAL ARE A 1576.37
H b A 1C 7. 7 %
HbA1 8.9 % HbF 0.4 %
[%]
15.0
10.0
5.0
0.0
0.00 1.00 2.00
[Min]
2025-06-20 14:54 root Page: 1 / 1
Patient Name : Mr.MRIDUL ROY Collected : 19/Jun/2025 06:46PM
Age/Gender : 59 Y 8 M 12 D /M Received : 20/Jun/2025 12:16PM
UHID/MR No : DLKH.0000004407 Reported : 20/Jun/2025 03:03PM
Visit ID : DLKHOPV6776 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PCC LAKHIMPUR DIBRUGARH
IP/OP NO : Center location : ,North Lakhimpur
TERMS AND CONDITIONS GOVERNING THIS REPORT
1. Reported results are for information and interpretation of the referring doctor or such other medical professionals, who understand
reporting units, reference ranges and limitation of technologies. Laboratories not be responsible for any interpretation whatsoever
2. This is computer generated medical diagnostics report that has been validated by an Authorized Medical Practitioner/Doctor. The
report does not need physical signature.
3. Partial reproduction of this report is not valid and should not be resorted to draw any conclusion.
4. In the case you are not the intended recipient of this report. Please immediately return the same to the concerned issuing desk. Any
disclosure, copy or distribution of any contents of this report, is unlawful and is strictly prohibited.
5. Results delays may occur due to unforeseen circumstances such as non-availability of kits, equipment breakdown, natural calamities,
IT downtime, logistic delays or any other unavoidable event. For certain tests based on analyte stability, criticality of results and in the
interest of patient for having appropriate medical diagnosis, the same test may be outsourced to other accredited laboratory.
6. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the verifications of
particulars have been confirmed by the patient or his / her representative at the point of generation of said specimen
7. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
8. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies
9. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
10. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only
SIN No:BI26357398
